Literature DB >> 28300874

Amniotic membrane as an option for treatment of acute Achilles tendon injury in rats.

Mariana de Castro Nicodemo1, Lia Renó das Neves2, Josafá Carvalho Aguiar3, Flaviane de Souza Brito4, Isabelle Ferreira5, Luciana Barros Sant'Anna6, Leandro José Raniero5, Rodrigo Álvaro Lopes Martins7, Paulo Roxo Barja8, Emilia Angela Lo Schiavo Arisawa9.   

Abstract

PURPOSE: To evaluate the effect of human amniotic membrane (hAM) fragment on inflammatory response, proliferation of fibroblast and organization of collagen fibers in injured tendon.
METHODS: Sixty rats were divided into 3 groups: C - surgical procedures without tendon lesion and with simulation of hAM application; I - surgical procedures, tendon injury and simulation of hAM application; T - surgical procedures, tendon injury and hAM application. These groups were subdivided into four experimental times (3, 7, 14 and 28 days). The samples underwent histological analysis and ATR-FTIR spectroscopy.
RESULTS: Histological analysis at 14 days, the T group showed collagen fibers with better alignment. At 28 days, the I group presented the characteristics described for the T group at 14 days, while this group presented aspects of a mature connective tissue. FT-IR analysis showed a clear distinction among the three groups at all experimental times and groups T and I presented more similarities to each other than to group C.
CONCLUSION: Acute injury of tendon treated with human amniotic membrane fragment showed a faster healing process, reduction in inflammatory response, intense proliferation of fibroblasts and organization of collagen fibers.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28300874     DOI: 10.1590/s0102-865020170205

Source DB:  PubMed          Journal:  Acta Cir Bras        ISSN: 0102-8650            Impact factor:   1.388


  7 in total

Review 1.  Current Progress in Tendon and Ligament Tissue Engineering.

Authors:  Wei Lee Lim; Ling Ling Liau; Min Hwei Ng; Shiplu Roy Chowdhury; Jia Xian Law
Journal:  Tissue Eng Regen Med       Date:  2019-06-26       Impact factor: 4.169

2.  Cryopreserved amniotic membrane and umbilical cord particulate matrix for partial rotator cuff tears: A case series.

Authors:  J Freeland Ackley; Michael Kolosky; Danielle Gurin; Robert Hampton; Richard Masin; David Krahe
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

3.  Myogenic differentiation of human amniotic mesenchymal cells and its tissue repair capacity on volumetric muscle loss.

Authors:  Di Zhang; Kai Yan; Jing Zhou; Tianpeng Xu; Menglei Xu; Jiayi Lin; Jiaxiang Bai; Gaoran Ge; Dan Hu; Weibing Si; Yuefeng Hao; Dechun Geng
Journal:  J Tissue Eng       Date:  2019-11-11       Impact factor: 7.813

4.  Evaluation of two distinct placental-derived membranes and their effect on tenocyte responses in vitro.

Authors:  John P McQuilling; Kelly A Kimmerling; Miranda C Staples; Katie C Mowry
Journal:  J Tissue Eng Regen Med       Date:  2019-06-13       Impact factor: 3.963

5.  Effect of norbixin-based poly(hydroxybutyrate) membranes on the tendon repair process after tenotomy in rats.

Authors:  Lízia Daniela E Silva Nascimento; Renata Amadei Nicolau; Antônio Luiz Martins Maia Filho; José Zilton Lima Verde Santos; Khetyma Moreira Fonseca; Danniel Cabral Leão Ferreira; Rayssilane Cardoso de Sousa; Vicente Galber Freitas Viana; Luiz Fernando Meneses Carvalho; José Figueredo-Silva
Journal:  Acta Cir Bras       Date:  2020-01-13       Impact factor: 1.388

6.  Amniotic membrane-mesenchymal stromal cells secreted factors and extracellular vesicle-miRNAs: Anti-inflammatory and regenerative features for musculoskeletal tissues.

Authors:  Enrico Ragni; Andrea Papait; Carlotta Perucca Orfei; Antonietta Rosa Silini; Alessandra Colombini; Marco Viganò; Francesca Libonati; Ornella Parolini; Laura de Girolamo
Journal:  Stem Cells Transl Med       Date:  2021-03-03       Impact factor: 6.940

7.  miRNA Reference Genes in Extracellular Vesicles Released from Amniotic Membrane-Derived Mesenchymal Stromal Cells.

Authors:  Enrico Ragni; Carlotta Perucca Orfei; Antonietta Rosa Silini; Alessandra Colombini; Marco Viganò; Ornella Parolini; Laura de Girolamo
Journal:  Pharmaceutics       Date:  2020-04-11       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.